NCT06221423View on ClinicalTrials.gov

Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Colorectal CancerMetastatic Colorectal CancerRefractory Colorectal Carcinoma
Interventions
DRUG

Fruquintinib Combined With TAS-102

Fruquintinib Combined With TAS-102

Trial Locations (1)

200032

RECRUITING

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT06221423 - Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter